β-Arrestins (βarrs) interact with G protein-coupled receptors (GPCRs) to desensitize G protein signaling, to initiate signaling on their own, and to mediate receptor endocytosis. Prior structural studies have revealed two unique conformations of GPCR-βarr complexes: the "tail" conformation, with βarr primarily coupled to the phosphorylated GPCR C-terminal tail, and the "core" conformation, where, in addition to the phosphorylated C-terminal tail, βarr is further engaged with the receptor transmembrane core. However, the relationship of these distinct conformations to the various functions of βarrs is unknown. Here, we created a mutant form of βarr lacking the "finger-loop" region, which is unable to form the core conformation but retains the ability to form the tail conformation. We find that the tail conformation preserves the ability to mediate receptor internalization and βarr signaling but not desensitization of G protein signaling. Thus, the two GPCR-βarr conformations can carry out distinct functions.
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GPCR | arrestin | endocytosis | signaling | desensitization O ver the past decade, significant efforts have been made to understand the molecular properties and regulatory mechanisms that control the function of β-arrestin (βarr) interactions with G protein-coupled receptors (GPCRs) (1, 2) . Once activated, GPCRs initiate a highly conserved signaling and regulatory cascade marked by interactions with: (i) heterotrimeric G proteins, which mediate their actions largely by promoting second-messenger generation (3); (ii) GPCR kinases (GRKs), which phosphorylate activated conformations of receptors (4); and (iii) βarrs, which bind to the phosphorylated receptors to mediate desensitization of G protein signaling and receptor internalization (5, 6) . In addition to their canonical function of desensitization and internalization, βarrs have been appreciated as independent signaling units by virtue of their crucial role as both adaptors and scaffolds for an increasing number of signaling pathways (7) (8) (9) (10) (11) .
There are two driving forces that mediate βarr interactions with an activated GPCR: phosphorylation of the C-terminal tail of the receptor by GRKs and/or binding to the transmembrane core of the receptor. How each of these interactions contributes to βarr functionality remains unclear. Moreover, GPCRs tend to either interact with βarr transiently, termed "class A" GPCRs [e.g., β 2 -adrenergic receptor (β 2 AR)], or tightly, known as "class B" GPCRs [e.g., vasopressin type 2 receptor (V 2 R)]. For the current study, we use a previously described chimeric β 2 V 2 R construct, which comprises the β 2 AR with its C-terminal tail exchanged with the V 2 R C-terminal tail (12) (13) (14) . The β 2 V 2 R construct provides an ideal system for studying a GPCR-βarr complex in vitro, because it maintains identical pharmacological properties to the WT β 2 AR and has a robustly increased class B affinity for βarr1, which allows stable β 2 V 2 R-βarr complexes to be formed and purified.
Structural insights have shed some light onto the complexity of the interaction between GPCRs and βarrs. A recent structural study of a constitutively active rhodopsin-arrestin fusion protein revealed high-resolution information about a single conformation of the complex in which the arrestin engaged via the transmembrane core of the receptor (12) . However, negative-stain electron microscopy (EM) analysis of an antigen-binding fragment 30 (Fab30)-stabilized β 2 V 2 R-βarr1-Fab30 complex demonstrated that the β 2 V 2 R-βarr1 complex assumes two unique conformations: one in which ∼63% of the βarr1 in the complex is bound only to the phosphorylated receptor C-terminal tail and appears to hang from the receptor ("tail" conformation) and a second more fully engaged conformation representing ∼37%, in which, in addition to the tail interaction, the Significance β-Arrestins (βarrs) interact with G protein-coupled receptors (GPCRs) to desensitize G protein signaling, initiate signaling on their own, and mediate receptor endocytosis. Using a panel of GPCRs believed to couple differently to βarrs, we demonstrate how distinct conformations of GPCR-βarr complexes are specialized to perform different subsets of these cellular functions. Our results thus provide a new signaling paradigm for the understanding of GPCRs, whereby a specific GPCR-βarr conformation mediates receptor desensitization, and another drives internalization and some forms of signaling.
finger-loop region (FLR) of βarr1 inserts into the transmembrane core of the receptor ("core" conformation) (13) .
It is not known whether different GPCR-βarr conformations mediate distinct functional outputs. Thus, we sought to identify βarr1 mutants that predominantly form complexes with β 2 V 2 R in one or the other conformation, and then to test their ability to promote βarr-mediated internalization, signaling, and desensitization of G protein signaling.
Results
We focused our mutagenesis approach on the FLR of βarr1 because this region mediates an essential interaction with the receptor transmembrane core (13, 15) that stabilizes the GPCRβarr complex core conformation (16) . Disrupting this interaction through βarr1 mutagenesis, we reasoned, would allow us to obtain a βarr1 that predominantly forms GPCR-βarr tail conformation complexes, and not any core-conformation complexes, when bound to GPCRs.
To identify βarr1 mutants that primarily form β 2 V 2 R-βarr1 complexes in the tail conformation, we devised a method to form (and purify) these complexes on a small scale (Fig. 1A) , and then applied single-particle classification analysis using negative-stain EM to assess their structural features ( Fig. 1 B-E) . Furthermore, we developed a camelid nanobody, Nb32, which binds to and stabilizes active βarr1 that predominantly complexes with β 2 V 2 R in the core conformation ( Fig. 1 B-F and Figs. S1 and S2). Using our method, the addition of Nb32 to the β 2 V 2 R-βarr1-Fab30 complex increased the percentage of β 2 V 2 R-βarr1 complexes in the core conformation from 34 to 63% (Fig. 1F and Figs. S1 and S2), thus allowing a more precise assessment of βarr1 mutants defective in their ability to form β 2 V 2 R-βarr1 core-conformation complexes.
None of the mutations in the FLR of βarr1 that were tested prevented βarr1 from forming complexes with β 2 V 2 R as analyzed by pull-down assays and EM ( Fig. 1 and Figs. S1 and S2). However, several mutants severely reduced the ability of βarr1 to bind to receptor via the core conformation in the β 2 V 2 R-βarr1-Fab30 complex, even in the presence of Nb32 (Fig. 1F) . Most notable is the βarr1 (ΔFLR) mutant (Fig. 1F, construct 2) , with the entire FLR removed, which led to a substantial decrease in the core conformation of the β 2 V 2 R-βarr1-Fab30 complex even in the presence of Nb32. Together, these results demonstrate that the βarr1 (ΔFLR) mutant is strongly impaired in its ability to interact with the receptor transmembrane core, and thus serves as a model for βarr1 that forms a complex with the β 2 V 2 R predominantly in the tail conformation.
Next, using the β 2 V 2 R, the cellular functionality of βarr1 (ΔFLR) was confirmed using well-established βarr1 recruitment and internalization assays (Fig. S3A) . Removal of the FLR did not impair agonist-mediated recruitment of βarr1 or βarr1-mediated receptor internalization, indicating that βarr1 (ΔFLR) can perform these functions for the β 2 V 2 R (Fig. S3A) . We then set out to test whether distinct conformations of GPCR-βarr1 complexes determine differential functional outcomes by using an array of well-established biochemical, cellular, and biophysical assays. In addition to the chimeric β 2 V 2 R, its more physiological relatives, β 2 AR and V 2 R, were studied in parallel.
Classical GPCR activation promotes translocation of βarr1 from the cytosol to the GPCRs in the plasma membrane, and subsequently facilitates intracellular trafficking of GPCRs to endosomes (14) . Thus, to ascertain the impact of the βarr1 (ΔFLR) mutant on recruitment to the β 2 AR, β 2 V 2 R, and V 2 R, as well as subsequent trafficking, confocal microscopy imaging was applied. Using this approach, we tracked the cellular localization of N-terminal SNAP-tagged GPCRs (SNAP-β 2 AR, SNAP-β 2 V 2 R, or SNAP-V 2 R) prelabeled with SNAP-Surface 649 fluorescence substrate and GFP-βarr1 (WT) or GFP-βarr1 (ΔFLR) in βarr1/ βarr2 double-knockout (DKO) HEK293 cells following agonist treatment (16) . The experiments demonstrate that βarr1 (WT or ΔFLR) is recruited to both the β 2 V 2 R and V 2 R, and that both mediate receptor internalization to endosomes, 30 min poststimulation, to a similar extent (Fig. 2) . In contrast, only the βarr1 (WT), but not the βarr1 (ΔFLR), is recruited to the β 2 AR upon agonist stimulation followed by receptor internalization.
The cellular trafficking pattern of βarr1 (WT or ΔFLR) was further quantified using bioluminescence resonance energy transfer (BRET) biosensors to monitor recruitment to the plasma membrane [Renilla reniformis green fluorescent protein (rGFP)-CAAX as a plasma membrane marker)] and early endosome (rGFP-FYVE as an early endosomal marker) upon agonist stimulation of the three GPCRs in DKO HEK293 cells (17) (Fig. 3A) . Agonist stimulation of β 2 AR, β 2 V 2 R, or V 2 R caused an increase in the BRET signal between RlucII-βarr1 (WT) and the plasma-membrane rGFP-CAAX biosensor (Fig. 3B and Fig. S3B ). With the βarr1 (ΔFLR), agonist stimulation of either β 2 V 2 R or V 2 R also increased the BRET signal between RlucII-βarr1 (ΔFLR) and rGFP-CAAX, but to a slightly reduced extent for the β 2 V 2 R compared with RlucIIβarr1 (WT) (Fig. 3B and Fig. S3B ). These findings indicate that both β 2 V 2 R and V 2 R are not dependent, to any large extent, on the core interaction to form a stable complex with βarr1. However, for the β 2 AR, there was no increased BRET signal between RlucII-βarr1 (ΔFLR) and rGFP-CAAX upon agonist stimulation, suggesting that the βarr1 (ΔFLR) is unable to be recruited to this GPCR ( Fig. 3B and Fig. S3B) . A significant, but slightly reduced, agonist-promoted BRET increase between RlucII-βarr1 (ΔFLR) and the early endosomal marker, rGFP-FYVE, biosensor was detected compared with βarr1 (WT) for the β 2 V 2 R or V 2 R. These results suggest that βarr1 (ΔFLR) is capable of mediating internalization of the β 2 V 2 R or V 2 R to early endosomes, although to a lesser extent than βarr1 (WT) (Fig. 3C and Fig. S3B ). In agreement with previous work (16) on the β 2 AR and its interaction with βarr1 showing that this class A GPCR recycles quickly and that βarr1 is not present in endosomes, no change in the BRET signal was detected between RlucII-βarr1 (WT or ΔFLR) and rGFP-FYVE following agonist treatment of β 2 AR-transfected DKO HEK293 cells (Fig. 3C and Fig. S3B ).
The scaffolding function of βarrs, as signal transducers, has been characterized for multiple signaling proteins, including c-Src (18, 19) . Formation of GPCR-βarr1-c-Src ternary complexes has been demonstrated to regulate multiple cellular functions downstream of various GPCRs (20) . Thus, to investigate the capacity of βarr1 in the GPCR-βarr1 tail conformation to scaffold c-Src, we evaluated the ability of βarr1 (WT or ΔFLR) to interact with c-Src upon activation of β 2 AR, β 2 V 2 R, or BRET 2 between rGFP-FYVE and RlucII-arr1 (WT or FLR): Fig. 3 . Interaction between βarr1 (WT or ΔFLR) and either rGFP-CAAX (plasma membrane marker) or rGFP-FYVE (early endosomal marker) upon agonist stimulation of β 2 AR, β 2 V 2 R, or V 2 R. (A) Schematic representation of the experimental design used to monitor agonist-promoted BRET between RlucII-βarr1 (WT or ΔFLR) and rGFP-CAAX or rGFP-FYVE. (B) BRET concentration-response experiments assessing the agonist-stimulated RlucII-βarr1 (WT or ΔFLR) recruitment to plasma membrane-located rGFP-CAAX. Upon agonist addition, a difference in BRET was detected between βarr1 (WT) and β 2 AR (P = 0.0022), but not between βarr1 (ΔFLR) and β 2 AR (P = 0.4306). Agonist-mediated changes in net BRET between βarr1 (WT) and βarr1 (ΔFLR) were detected for both the β 2 AR (P = 0.0015) and β 2 V 2 R (P < 0.0001), but not for V 2 R (P = 0.0820). (C) BRET concentration-response experiments assessing the agonist-stimulated RlucIIβarr1 (WT or ΔFLR) localization to early endosomal-located rGFP-FYVE. Upon agonist addition, no BRET difference was detected between either βarr1 (WT) or βarr1 (ΔFLR) and β 2 AR (P = 0.4188 or P = 0.9016, respectively). Agonist-mediated changes in net BRET between βarr1 (WT) and βarr1 (ΔFLR) were detected for β 2 V 2 R (P = 0.0034) and V 2 R (P = 0.0014), but not for β 2 AR (P = 0.9057). In all experiments, BRET was measured 30 min following addition of agonist or vehicle. To stimulate the GPCRs, 1 μM BI-167107 was applied for the β 2 AR and β 2 V 2 R, and 100 nM arginine vasopressin (AVP) was applied for the V 2 R. Data are expressed as net BRET absolute values, represent the mean ± SE, are pooled from four to six experiments, and are analyzed using either a paired t test (two conditions) or one-way ANOVA with Tukey's multiple comparisons post hoc test (three or more conditions).
V 2 R in DKO HEK293 cells by coimmunoprecipitation. As expected, βarr1 (WT) effectively binds c-Src upon stimulation of all three GPCRs (Fig. 4 A and B) . We also observed that the ability of the βarr1 (ΔFLR) to scaffold c-Src, upon stimulation of the β 2 V 2 R and V 2 R, was slightly reduced relative to βarr1 (WT) (Fig. 4 A and B) . In contrast, βarr1 (ΔFLR) does not interact with c-Src upon β 2 AR stimulation, as might be expected, because βarr1 (ΔFLR) is not recruited to β 2 AR. The scaffolding function of βarr1 (ΔFLR) was further explored by Glutathione Sepharose (GST) pull-down assays using purified 6×His-βarr1 (WT or ΔFLR) and GST-c-Src either in the absence or presence of the phosphorylated V 2 R C-terminal peptide (V 2 Rpp). In the presence of V 2 Rpp, an increased interaction was observed between βarr1 (WT or ΔFLR) and GST-c-Src (Fig. S3C) . The βarr1 (ΔFLR) mutant is slightly impaired relative to βarr1 (WT) with respect to scaffolding c-Src in vitro, a trend also observed in our aforementioned cellular studies of both βarr1-c-Src scaffolding and βarr1-mediated GPCR internalization to endosomes (Figs. 3C and 4A) .
βarr1 is known to promote desensitization of GPCR-stimulated G protein-mediated signaling. The mechanism underlying βarr1-mediated desensitization is thought to involve the interaction between βarr and the receptor core; this core conformation, presumably, sterically blocks the G protein-binding site in the receptor core (21) . To assess the importance of the FLR of βarr1 for receptor desensitization directly, we monitored the attenuation of agonist-stimulated heterotrimeric Gs protein signaling, measured here as cAMP accumulation, in either the DKO (for the β 2 AR) or a βarr1/βarr2/β 2 AR triple-knockout (for the β 2 V 2 R and V 2 R) HEK293 cell line expressing ICUE2, a fluorescence resonance energy transfer biosensor-detecting cytoplasmic cAMP (22) . This ICUE2 biosensor measures cAMP concentration in real time, and thus represents equilibrium between production and degradation of cAMP. β 2 AR, β 2 V 2 R, and V 2 R were all expressed at near-endogenous levels (∼100-400 fmol/mg), together with GRK2-CAAX, to ensure effective receptor phosphorylation and βarr1 recruitment upon agonist challenge. For all three GPCRs, agonist stimulation led to a rapid onset of cAMP generation, and this signal was only minimally reduced throughout the 30-min duration of the experiment (Fig. 4C) .
We next coexpressed βarr1 (WT or ΔFLR) to test its ability to desensitize G protein signaling. Within the first 2 min of agonist challenge, β 2 AR, β 2 V 2 R, and V 2 R all stimulated cAMP production to a similar extent. Beyond 2 min, βarr1 (WT) attenuated the cAMP responses differently among these receptors (Fig.  4C) , and most prominently for the WT β 2 AR, where the addition of βarr1 (WT) led to rapid, but incomplete, desensitization. In contrast, βarr1 (ΔFLR) did not mediate any desensitization of the β 2 AR-stimulated cAMP response because it is not recruited HEK293 DKO cells were transfected with plasmids for β 2 AR, β 2 V 2 R, or V 2 R, c-Src, and HA-βarr1 (WT or ΔFLR). Serum-starved cells were stimulated with or without agonist BI-167107 (1 μM) or AVP (100 nM) for 10 min and then cross-linked using dithiobis(succinimidyl propionate); finally, anti-HA beads were used to pull down βarr1 (WT or ΔFLR). The amount of total c-Src bound to HA-βarr1 (WT or ΔFLR) was determined by immunoblotting (IB). Data represent the mean ± SE of four to five experiments. One-way ANOVA was performed to determine statistical differences between basal and agonist-stimulated states (****P < 0.0001), or agonist-stimulated states in βarr1 (WT)-and βarr1 (ΔFLR)-transfected cells (##P < 0.01, ####P < 0.0001). (C) βarr1-mediated desensitization of Gs-promoted cAMP generation by the β 2 AR, β 2 V 2 R, or V 2 R. Real-time cAMP measurements, using ICUE2-expressing HEK293 cells, in response to agonist stimulation of β 2 AR, β 2 V 2 R, and V 2 R are shown. For the β 2 AR and β 2 V 2 R, 1 μM BI-167107 was used to stimulate cells. For V 2 R, 100 nM AVP was used to stimulate cells. For each GPCR, control plasmid (Mock, black), βarr1 (WT) (blue), or βarr1 (ΔFLR) (red) was transfected. Surface expression of each GPCR was matched within each βarr1 transfection condition. Data represent the mean ± SE of three to four experiments and n ≥ 44 cells. Area under the curve (A.U.C.) from 2 min after agonist stimulation to the end of the experiment was used to calculate desensitization of the cAMP response for each GPCR, and one-way ANOVA was performed to determine statistical differences relative to Mock (**P < 0.01, ***P < 0.001) and βarr1 (WT) (#P < 0.05, ###P < 0.001) responses. Forsk, forskolin.
to this receptor. βarr1 (WT)-mediated desensitization was also observed at the β 2 V 2 R-stimulated cAMP response (Fig. 4C) . βarr1 (WT) did not have a significant effect on V 2 R-stimulated cAMP signaling, which agrees with previous work (23) . Most strikingly, expression of βarr1 (ΔFLR) did not lead to any significant desensitization of G protein signaling for any of the GPCRs tested (Fig. 4C ). These results (Fig. 4 A and C) demonstrate that the FLR domain of βarr1, presumably through its role in forming the core interaction, is crucial for βarr1-mediated desensitization of G protein signaling.
Discussion
Our results can be interpreted in the context of the classification of GPCRs according to the strength of their interaction with βarrs. Class A GPCRs, such as the β 2 AR, bind βarrs relatively weakly and dissociate from them in the course of internalization. They thus recycle rapidly to the plasma membrane. Class B GPCRs, such as the V 2 R or the β 2 V 2 R chimera, bind βarrs much more tightly and, once internalized, remain bound to βarrs and resident in endosomes for significant periods of time. They recycle only slowly to the plasma membrane. For class B GPCRs, the GPCRβarr complex, in the tail conformation, appears to be capable of promoting βarr-mediated receptor internalization and some forms of signaling, but not desensitization of G protein signaling, which appears to be the exclusive purview of the core-conformation complex (Fig. 4A) . A recent study showed that some βarr-mediated functions are maintained when recruited to a potential coredeficient GPCR mutant, which supports our conclusions with respect to the function of the tail conformation complex (24) . However, the study did not experimentally demonstrate any biological role of the core conformation. Our finding that the core-conformation complex appears to be crucial for mediating desensitization is in agreement with the classical notion that G proteins and βarrs compete for overlapping binding sites in the receptor transmembrane core (21) . Interestingly, for the class A β 2 AR, which binds βarr more weakly, the tail conformation complex appears to be too unstable to lead to effective recruitment of the βarr1 (ΔFLR). Our data thus suggest that for such GPCRs, the tail conformation complex might not exist in a stable enough form to participate in βarr-mediated activities. In addition, we have recently demonstrated that some GPCRs, such as the β 2 V 2 R and V 2 R but not the β 2 AR, can form GPCRGs-βarr "megaplexes," and thus activate G protein from internalized compartments (16) . In these megaplexes, the receptor binds βarr in the tail conformation complex. Interestingly, in the current study, we find a clear correlation between the GPCRs that form GPCR-βarr1 tail conformation complexes and GPCRs that can activate G protein from internalized compartments. In contrast, GPCRs that rely more heavily on the core conformation do not seem to activate G protein after being internalized by βarr.
